
Actithera draws new investors to radiopharma drug pitch
Dive Brief: Actithera, a radiopharmaceutical drugmaker based in Oslo, Norway and Cambridge, Massachusetts, has raised just under $76 million in Series A venture financing to build out its cancer drug pipeline. In a Wednesday statement, the biotechnology …